Cardol triene inhibits dengue infectivity by targeting kl loops and preventing envelope fusion
暂无分享,去创建一个
T. Rungrotmongkol | W. Chavasiri | Siwaporn Boonyasuppayakorn | Thanaphon Saelee | Aphinya Suroengrit | Parichat Kanyaboon | K. Hengphasatporn
[1] A. Wagner,et al. Inhibition of dengue virus infection by mannoside glycolipid conjugates , 2018, Antiviral research.
[2] K. Ruxrungtham,et al. A novel flavanone derivative inhibits dengue virus fusion and infectivity , 2018, Antiviral research.
[3] W. Chavasiri,et al. Halogenated Chrysins Inhibit Dengue and Zika Virus Infectivity , 2017, Scientific Reports.
[4] C. Chanchao,et al. Molecular mechanism of cardol, isolated from Trigona incisa stingless bee propolis, induced apoptosis in the SW620 human colorectal cancer cell line , 2017, BMC Pharmacology and Toxicology.
[5] O. Burrone,et al. Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells , 2017, Scientific Reports.
[6] M. Groppo,et al. Schistosomicidal Activity of Alkyl-phenols from the Cashew Anacardium occidentale against Schistosoma mansoni Adult Worms. , 2016, Journal of agricultural and food chemistry.
[7] P. Bhattarakosol,et al. Simplified dengue virus microwell plaque assay using an automated quantification program. , 2016, Journal of virological methods.
[8] P. Marimuthu,et al. Trends in clinical trials of dengue vaccine , 2016, Perspectives in clinical research.
[9] I. Kubo,et al. Superoxide anion scavenging activity of alk(en)yl phenol compounds by using PMS-NADH system , 2016, Heliyon.
[10] G. Haegeman,et al. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A. , 2015, Antiviral research.
[11] J. Chu,et al. Antiviral activity of silymarin against chikungunya virus , 2015, Scientific Reports.
[12] G. Perng,et al. Current Neurological Observations and Complications of Dengue Virus Infection , 2015, Current Neurology and Neuroscience Reports.
[13] J. Neyts,et al. Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors. , 2015, Bioorganic & medicinal chemistry letters.
[14] E. Mubofu,et al. Potential Biological Applications of Bio-Based Anacardic Acids and Their Derivatives , 2015, International journal of molecular sciences.
[15] Qiang Liu,et al. The Inhibitory Effects of Anacardic Acid on Hepatitis C Virus Life Cycle , 2015, PloS one.
[16] D. Kerami,et al. Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2 , 2015, Drug target insights.
[17] T. Rungrotmongkol,et al. Binding mode and free energy prediction of fisetin/β-cyclodextrin inclusion complexes , 2014, Beilstein journal of organic chemistry.
[18] J. Connolly,et al. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. , 2014, The Lancet. Infectious diseases.
[19] C. Chanchao,et al. In vitro cytotoxicity of Indonesian stingless bee products against human cancer cell lines. , 2014, Asian Pacific journal of tropical biomedicine.
[20] C. C. da Silva,et al. Natural Products as Source of Potential Dengue Antivirals , 2014, Molecules.
[21] T. Rungrotmongkol,et al. Enhanced stability of a naringenin/2,6-dimethyl β-cyclodextrin inclusion complex: molecular dynamics and free energy calculations based on MM- and QM-PBSA/GBSA. , 2014, Journal of molecular graphics & modelling.
[22] R. Padmanabhan,et al. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity , 2014, Antiviral Research.
[23] A. Wilder-Smith,et al. Epidemiology of dengue: past, present and future prospects , 2013, Clinical epidemiology.
[24] Richard J Kuhn,et al. Dengue structure differs at the temperatures of its human and mosquito hosts , 2013, Proceedings of the National Academy of Sciences.
[25] N. Nomura,et al. Sulfated Polysaccharide, Curdlan Sulfate, Efficiently Prevents Entry/Fusion and Restricts Antibody-Dependent Enhancement of Dengue Virus Infection In Vitro: A Possible Candidate for Clinical Application , 2013, PLoS neglected tropical diseases.
[26] S. Halstead,et al. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection , 2013, Archives of Virology.
[27] S. Kamiya,et al. Anacardic acid, a histone acetyltransferase inhibitor, modulates LPS-induced IL-8 expression in a human alveolar epithelial cell line A549 , 2013, F1000Research.
[28] R. Peeling,et al. Lovastatin for adult patients with dengue: protocol for a randomised controlled trial , 2012, Trials.
[29] T. Rungrotmongkol,et al. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1. , 2012, Journal of molecular graphics & modelling.
[30] C. T. Tam,et al. Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] Niranjan Nagarajan,et al. A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients , 2012, The Journal of infectious diseases.
[32] Traian Sulea,et al. Solvated Interaction Energy (SIE) for Scoring Protein-Ligand Binding Affinities. 2. Benchmark in the CSAR-2010 Scoring Exercise , 2011, J. Chem. Inf. Model..
[33] E. De Clercq,et al. A time-of–drug addition approach to target identification of antiviral compounds , 2011, Nature Protocols.
[34] J. Farrar,et al. A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults , 2010, PLoS neglected tropical diseases.
[35] M. Pollastri,et al. Overview on the Rule of Five , 2010, Current protocols in pharmacology.
[36] A. Kozubek,et al. Biological activity of phenolic lipids , 2010, Cellular and Molecular Life Sciences.
[37] P. Shi,et al. A small molecule fusion inhibitor of dengue virus. , 2009, Antiviral research.
[38] E. Jacoby,et al. A Small-Molecule Dengue Virus Entry Inhibitor , 2009, Antimicrobial Agents and Chemotherapy.
[39] A. Mark,et al. Disturb or stabilize? A molecular dynamics study of the effects of resorcinolic lipids on phospholipid bilayers. , 2009, Biophysical journal.
[40] K. Cieślik-Boczula,et al. The effect of 3-pentadecylphenol on DPPC bilayers ATR-IR and 31P NMR studies. , 2009, Biophysical chemistry.
[41] Paul R. Young,et al. Identification of novel target sites and an inhibitor of the dengue virus E protein , 2009, J. Comput. Aided Mol. Des..
[42] A. Kozubek,et al. Membrane perturbing properties of natural phenolic and resorcinolic lipids , 2008, FEBS letters.
[43] Imran Siddiqi,et al. Solvated Interaction Energy (SIE) for Scoring Protein-Ligand Binding Affinities, 1. Exploring the Parameter Space , 2007, J. Chem. Inf. Model..
[44] C. King,et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] Bostjan Kobe,et al. The Role of histidine residues in low-pH-mediated viral membrane fusion. , 2006, Structure.
[46] Nathan A. Baker,et al. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..
[47] Charles L. Brooks,et al. Detailed analysis of grid‐based molecular docking: A case study of CDOCKER—A CHARMm‐based MD docking algorithm , 2003, J. Comput. Chem..
[48] Y. Modis,et al. A ligand-binding pocket in the dengue virus envelope glycoprotein , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[49] C. King,et al. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. , 2003, Virology.
[50] A. Kozubek,et al. Formation of liposomes by resorcinolic lipids, single-chain phenolic amphiphiles from Anacardium occidentale L. , 2001, Biochimica et biophysica acta.
[51] P. Kollman,et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.
[52] F Darvas,et al. Prediction of distribution coefficient from structure. 1. Estimation method. , 1997, Journal of pharmaceutical sciences.
[53] D. Gubler,et al. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. , 1995, Emerging infectious diseases.
[54] Peter C. Jurs,et al. Estimation of pKa for organic oxyacids using calculated atomic charges , 1993, J. Comput. Chem..
[55] V. Stollar,et al. Low pH-induced cell fusion in flavivirus-infected Aedes albopictus cell cultures. , 1990, The Journal of general virology.
[56] M. Ruiz,et al. Flaviviruses can mediate fusion from without in Aedes albopictus mosquito cell cultures. , 1989, Virus research.
[57] G. Elizondo,et al. Genotoxic and cytostatic effects of 6-pentadecyl salicylic anacardic acid in transformed cell lines and peripheral blood mononuclear cells. , 2015, Mutation research. Genetic toxicology and environmental mutagenesis.
[58] C. Chanchao,et al. Propolis from the Stingless Bee Trigona incisa from East Kalimantan, Indonesia, Induces In Vitro Cytotoxicity and Apoptosis in Cancer Cell lines. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[59] Traian Sulea,et al. The solvated interaction energy method for scoring binding affinities. , 2012, Methods in molecular biology.